Trial Profile

A Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile of Single Ascending Doses of REL-1017 (d-Methadone) in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Aug 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Esmethadone (Primary)
Indications Neuropathic pain
Focus Adverse reactions
Acronyms SAD
Sponsors Relmada Therapeutics

Most Recent Events

01 Apr 2019 Results from two studies evaluating the safety,pharmacokinetics and tolerability of oral doses of D-methadone in healthy opioid naive subjects,published in the Journal of Clinical Psychopharmacology
10 Jun 2015 Status changed from recruiting to completed, according to a Relmada Therapeutics media release.
17 Mar 2015 Status changed from not yet recruiting to recruiting according to Relmada media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com